Current Role of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) in Non-Small Cell Lung Cancer (NSCLC): Which Patients and Why

Last Modified: October 8, 2004

Conference Dates: December 4, 2004
Conference Location: Chicago, IL


Sponsoring Group:

Conference Web Page URL: www.thecbce.com/futureprograms.asp

Topics Covered: Overview of EGFR Small-Molecule TKIs, Update on Recent Clinical Data for Small-Molecule TKIs, Second-Line Options for the Treatment of NSCLC, Clinical Variables of Patient Benefit: Who Should We Be Treating?, EGFR Small-Molecule TKIs and Rash: What Does it Mean?, Somatic Mutations and Response to EGFR Small-Molecule TKIs, Case Studies

Conference Objectives:

Who Should Attend: This activity is designed primarily for medical oncologists and other healthcare professionals interested in the treatment of cancer.

Conference Agenda:

Registration Information: To register for this meeting, please visit the conference website at www.thecbce.com/futureprograms.asp or e-mail info@thecbce.com

Continuing Education: Yes

Blogs

Breaking news: Supreme Court votes to uphold Affordable Care Act Subsidies
by Christina Bach, MSW, LCSW, OSW-C
June 26, 2015